142 related articles for article (PubMed ID: 7912753)
1. [Analysis of loss of heterozygosity (LOH) at the p53 and Rb suppressor genes in urinary bladder carcinoma].
Tamada H; Suzuki Y; Tamura G
Nihon Hinyokika Gakkai Zasshi; 1994 May; 85(5):722-30. PubMed ID: 7912753
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity at the p53, RB, DCC and APC tumor suppressor gene loci in human bladder cancer.
Miyamoto H; Shuin T; Ikeda I; Hosaka M; Kubota Y
J Urol; 1996 Apr; 155(4):1444-7. PubMed ID: 8632608
[TBL] [Abstract][Full Text] [Related]
3. Detection of LOH of the RB1 gene in bladder cancers by PCR-RFLP.
Açikbas I; Keser I; Kiliç S; Bağci H; Karpuzoğlu G; Lüleci G
Urol Int; 2002; 68(3):189-92. PubMed ID: 11919466
[TBL] [Abstract][Full Text] [Related]
4. Detection of loss of heterozygosity in the p53 tumor-suppressor gene with PCR in the urine of patients with bladder cancer.
Friedrich MG; Erbersdobler A; Schwaibold H; Conrad S; Huland E; Huland H
J Urol; 2000 Mar; 163(3):1039-42. PubMed ID: 10688045
[TBL] [Abstract][Full Text] [Related]
5. Loss of RB protein expression in primary bladder cancer correlates with loss of heterozygosity at the RB locus and tumor progression.
Xu HJ; Cairns P; Hu SX; Knowles MA; Benedict WF
Int J Cancer; 1993 Mar; 53(5):781-4. PubMed ID: 8449603
[TBL] [Abstract][Full Text] [Related]
6. Relevance of p53 gene alterations for tumor recurrence in patients with superficial transitional cell carcinoma of the bladder.
Friedrich MG; Riethdorf S; Erbersdobler A; Tiemer C; Schwaibold H; Sölter JK; Huland E; Riethdorf L; Conrad S; Hammerer PG; Huland H
Eur Urol; 2001 Feb; 39(2):159-66. PubMed ID: 11223675
[TBL] [Abstract][Full Text] [Related]
7. The loss of heterozygosity in retinoblastoma and p53 suppressor genes as a prognostic indicator for head and neck cancer.
Gleich LL; Li YQ; Biddinger PW; Gartside PS; Stambrook PJ; Pavelic ZP; Gluckman JL
Laryngoscope; 1996 Nov; 106(11):1378-81. PubMed ID: 8914904
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity at the RB locus is frequent and correlates with muscle invasion in bladder carcinoma.
Cairns P; Proctor AJ; Knowles MA
Oncogene; 1991 Dec; 6(12):2305-9. PubMed ID: 1766677
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity of the retinoblastoma and p53 genes in primary cervical carcinomas with human papillomavirus infection.
Kim JW; Lee CG; Han SM; Kim KS; Kim JO; Lee JM; Kim IK; Namkoong SE
Gynecol Oncol; 1997 Nov; 67(2):215-21. PubMed ID: 9367711
[TBL] [Abstract][Full Text] [Related]
10. Correlation of allelic loss of the P53 gene and tumor grade, stage, and malignant progression in bladder cancer.
Tsutsumi M; Sugano K; Yamaguchi K; Kakizoe T; Akaza H
Int J Urol; 1997 Jan; 4(1):74-8. PubMed ID: 9179671
[TBL] [Abstract][Full Text] [Related]
11. [Loss of heterozygosity of tumor suppressor genes at chromosome 3p in transitional cell carcinoma of urinary bladder].
Xiao Z; Zhang J; Zheng S; Li C; He Z; Cheng S; Gao Y
Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1375-7. PubMed ID: 12509916
[TBL] [Abstract][Full Text] [Related]
12. LOH and mutational analysis of p53 alleles in mouse urinary bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl) nitrosamine.
Morimura K; Yamamoto S; Murai T; Mori S; Chen TX; Wanibuchi H; Fukushima S
Carcinogenesis; 1999 Apr; 20(4):715-8. PubMed ID: 10223204
[TBL] [Abstract][Full Text] [Related]
13. p53 mutations and prognosis in bladder tumors.
Uchida T; Wada C; Ishida H; Wang C; Egawa S; Yokoyama E; Kameya T; Koshiba K
J Urol; 1995 Apr; 153(4):1097-104. PubMed ID: 7869472
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity of the retinoblastoma gene is correlated with the altered pRb expression in human endometrial cancer.
Semczuk A; Marzec B; Roessner A; Jakowicki JA; Wojcierowski J; Schneider-Stock R
Virchows Arch; 2002 Dec; 441(6):577-83. PubMed ID: 12461615
[TBL] [Abstract][Full Text] [Related]
15. Infrequent loss of heterozygosity of the major tumour suppressor genes in Indian oral cancers.
Kannan S; Yokozaki H; Jayasree K; Sebastian P; Mathews A; Abraham EK; Nair MK; Tahara E
Int J Oral Maxillofac Surg; 2002 Aug; 31(4):414-8. PubMed ID: 12361076
[TBL] [Abstract][Full Text] [Related]
16. Observations on tumor and metastatic suppressor gene status in endometrial carcinoma with particular emphasis on p53.
Ambros RA; Vigna PA; Figge J; Kallakury BV; Mastrangelo A; Eastman AY; Malfetano J; Figge HL; Ross JS
Cancer; 1994 Mar; 73(6):1686-92. PubMed ID: 8156496
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity frequency at the Trp53 locus in p53-deficient (+/-) mouse tumors is carcinogen-and tissue-dependent.
French JE; Lacks GD; Trempus C; Dunnick JK; Foley J; Mahler J; Tice RR; Tennant RW
Carcinogenesis; 2001 Jan; 22(1):99-106. PubMed ID: 11159747
[TBL] [Abstract][Full Text] [Related]
18. Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression.
Quentin T; Henke C; Korabiowska M; Schlott T; Zimmerman B; Kunze E
Anticancer Res; 2004; 24(2B):1011-23. PubMed ID: 15161057
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas.
Ishikawa J; Xu HJ; Hu SX; Yandell DW; Maeda S; Kamidono S; Benedict WF; Takahashi R
Cancer Res; 1991 Oct; 51(20):5736-43. PubMed ID: 1913692
[TBL] [Abstract][Full Text] [Related]
20. Role of chromosome 9 in human bladder cancer.
Miyao N; Tsai YC; Lerner SP; Olumi AF; Spruck CH; Gonzalez-Zulueta M; Nichols PW; Skinner DG; Jones PA
Cancer Res; 1993 Sep; 53(17):4066-70. PubMed ID: 8358736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
